Chintan Haria, fund manager at ICICI Prudential Mutual Fund says, pharma is a multiple-year growth story. The valuations of pharma stocks had become lofty around a year ago, but post the correction in them over the past six months to one year period, pharma stocks have become a good contrarian buy right now, he added.
